Patents by Inventor Simon H. DROUIN

Simon H. DROUIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Purified forms of rofecoxib, methods of manufacture and use
    Patent number: 11872206
    Abstract: The subject matter disclosed herein relates to rofecoxib, also known as TRM-201 or RXB-201, its method of manufacture, and use. In certain aspects, the highly pure or substantially pure rofecoxib as provided herein has a favorable purity profile and is the active ingredient in a pharmaceutical composition that is administered to treat or prevent a number of conditions, including pain associated with a condition caused by a bleeding disorder.
    Type: Grant
    Filed: July 1, 2022
    Date of Patent: January 16, 2024
    Assignee: Tremeau Pharmaceuticals, Inc.
    Inventors: Raymond D. Skwierczynski, Bradford C. Sippy, Jean-Marie Schneider, Simon H. Drouin, Charles Guerin
  • Purified forms of rofecoxib, methods of manufacture and use
    Patent number: 11617735
    Abstract: The subject matter disclosed herein relates to rofecoxib, also known as TRM-201 or RXB-201, its method of manufacture, and use. In certain aspects, the highly pure or substantially pure rofecoxib as provided herein has a favorable purity profile and is the active ingredient in a pharmaceutical composition that is administered to treat or prevent a number of conditions, including pain associated with a condition caused by a bleeding disorder.
    Type: Grant
    Filed: June 28, 2022
    Date of Patent: April 4, 2023
    Assignee: Tremeau Pharmaceuticals, Inc.
    Inventors: Raymond D. Skwierczynski, Bradford C. Sippy, Jean-Marie Schneider, Simon H. Drouin, Charles Guerin
  • Purified forms of rofecoxib, methods of manufacture and use
    Patent number: 11576890
    Abstract: The subject matter disclosed herein relates to rofecoxib, also known as TRM-201 or RXB-201, its method of manufacture, and use. In certain aspects, the highly pure or substantially pure rofecoxib as provided herein has a favorable purity profile and is the active ingredient in a pharmaceutical composition that is administered to treat or prevent a number of conditions, including pain associated with a condition caused by a bleeding disorder.
    Type: Grant
    Filed: February 26, 2021
    Date of Patent: February 14, 2023
    Assignee: Tremeau Pharmaceuticals, Inc.
    Inventors: Raymond D. Skwierczynski, Bradford C. Sippy, Jean-Marie Schneider, Simon H. Drouin, Charles Guerin
  • Purified forms of rofecoxib, methods of manufacture and use
    Patent number: 11559509
    Abstract: The subject matter disclosed herein relates to rofecoxib, also known as TRM-201 or RXB-201, its method of manufacture, and use. In certain aspects, the highly pure or substantially pure rofecoxib as provided herein has a favorable purity profile and is the active ingredient in a pharmaceutical composition that is administered to treat or prevent a number of conditions, including pain associated with a condition caused by a bleeding disorder.
    Type: Grant
    Filed: June 28, 2022
    Date of Patent: January 24, 2023
    Assignee: Tremeau Pharmaceuticals, Inc.
    Inventors: Raymond D. Skwierczynski, Bradford C. Sippy, Jean-Marie Schneider, Simon H. Drouin, Charles Guerin
  • PURIFIED FORMS OF ROFECOXIB, METHODS OF MANUFACTURE AND USE
    Publication number: 20220409568
    Abstract: The subject matter disclosed herein relates to rofecoxib, also known as TRM-201 or RXB-201, its method of manufacture, and use. In certain aspects, the highly pure or substantially pure rofecoxib as provided herein has a favorable purity profile and is the active ingredient in a pharmaceutical composition that is administered to treat or prevent a number of conditions, including pain associated with a condition caused by a bleeding disorder.
    Type: Application
    Filed: June 28, 2022
    Publication date: December 29, 2022
    Applicant: Tremeau Pharmaceuticals, Inc.
    Inventors: Raymond D. Skwierczynski, Bradford C. Sippy, Jean-Marie Schneider, Simon H. Drouin, Charles Guerin
  • PURIFIED FORMS OF ROFECOXIB, METHODS OF MANUFACTURE AND USE
    Publication number: 20220378736
    Abstract: The subject matter disclosed herein relates to rofecoxib, also known as TRM-201 or RXB-201, its method of manufacture, and use. In certain aspects, the highly pure or substantially pure rofecoxib as provided herein has a favorable purity profile and is the active ingredient in a pharmaceutical composition that is administered to treat or prevent a number of conditions, including pain associated with a condition caused by a bleeding disorder.
    Type: Application
    Filed: July 1, 2022
    Publication date: December 1, 2022
    Applicant: Tremeau Pharmaceuticals, Inc.
    Inventors: Raymond D. Skwierczynski, Bradford C. Sippy, Jean-Marie Schneider, Simon H. Drouin, Charles Guerin
  • PURIFIED FORMS OF ROFECOXIB, METHODS OF MANUFACTURE AND USE
    Publication number: 20220362206
    Abstract: The subject matter disclosed herein relates to rofecoxib, also known as TRM-201 or RXB-201, its method of manufacture, and use. In certain aspects, the highly pure or substantially pure rofecoxib as provided herein has a favorable purity profile and is the active ingredient in a pharmaceutical composition that is administered to treat or prevent a number of conditions, including pain associated with a condition caused by a bleeding disorder.
    Type: Application
    Filed: June 28, 2022
    Publication date: November 17, 2022
    Applicant: Tremeau Pharmaceuticals, Inc.
    Inventors: Raymond D. Skwierczynski, Bradford C. Sippy, Jean-Marie Schneider, Simon H. Drouin, Charles Guerin
  • PURIFIED FORMS OF ROFECOXIB, METHODS OF MANUFACTURE AND USE
    Publication number: 20210236455
    Abstract: The subject matter disclosed herein relates to rofecoxib, also known as TRM-201 or RXB-201, its method of manufacture, and use. In certain aspects, the highly pure or substantially pure rofecoxib as provided herein has a favorable purity profile and is the active ingredient in a pharmaceutical composition that is administered to treat or prevent a number of conditions, including pain associated with a condition caused by a bleeding disorder.
    Type: Application
    Filed: February 26, 2021
    Publication date: August 5, 2021
    Applicant: Tremeau Pharmaceuticals, Inc.
    Inventors: Raymond D. Skwierczynski, Bradford C. Sippy, Jean-Marie Schneider, Simon H. Drouin, Charles Guerin
  • Purified forms of rofecoxib, methods of manufacture and use
    Patent number: 10987337
    Abstract: The subject matter disclosed herein relates to rofecoxib, also known as TRM-201 or RXB-201, its method of manufacture, and use. In certain aspects, the highly pure or substantially pure rofecoxib as provided herein has a favorable purity profile and is the active ingredient in a pharmaceutical composition that is administered to treat or prevent a number of conditions, including pain associated with a condition caused by a bleeding disorder.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: April 27, 2021
    Assignee: Tremeau Pharmaceuticals, Inc.
    Inventors: Raymond D. Skwierczynski, Bradford C. Sippy, Jean-Marie Schneider, Simon H. Drouin, Charles Guerin
  • PURIFIED FORMS OF ROFECOXIB, METHODS OF MANUFACTURE AND USE
    Publication number: 20200206182
    Abstract: The subject matter disclosed herein relates to rofecoxib, also known as TRM-201 or RXB-201, its method of manufacture, and use. In certain aspects, the highly pure or substantially pure rofecoxib as provided herein has a favorable purity profile and is the active ingredient in a pharmaceutical composition that is administered to treat or prevent a number of conditions, including pain associated with a condition caused by a bleeding disorder.
    Type: Application
    Filed: December 16, 2019
    Publication date: July 2, 2020
    Inventors: Bradford C. SIPPY, Raymond SKWIERCZYNSKI, Jean-Marie SCHNEIDER, Simon H. DROUIN, Charles GUERIN